Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-162455
Filing Date
2022-05-27
Accepted
2022-05-27 17:01:28
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d318326d10ka.htm   iXBRL 10-K/A 72612
2 EX-23.2 d318326dex232.htm EX-23.2 1845
3 EX-31.5 d318326dex315.htm EX-31.5 9287
4 EX-31.6 d318326dex316.htm EX-31.6 9202
  Complete submission text file 0001193125-22-162455.txt   335481

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA plrx-20211231.xsd EX-101.SCH 5003
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plrx-20211231_cal.xml EX-101.CAL 925
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plrx-20211231_def.xml EX-101.DEF 19647
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20211231_lab.xml EX-101.LAB 30617
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20211231_pre.xml EX-101.PRE 21463
12 EXTRACTED XBRL INSTANCE DOCUMENT d318326d10ka_htm.xml XML 7943
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39303 | Film No.: 22978701
SIC: 2834 Pharmaceutical Preparations